Protagonist Therapeutics Inc (PTGX)

39.30 -1.30 (-3.20%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Protagonist Therapeutics Cash and Short Term Investments (Quarterly): 468.72M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Assembly Biosciences Inc 94.95M
Precision BioSciences Inc 101.20M
Entrada Therapeutics Inc 449.34M
NovaBay Pharmaceuticals Inc 0.776M
Palatin Technologies Inc 2.384M